Alexander Crichton
@vascularabc
Postdoc vascular research fellow at Houston Methodist hospital, OOPR West Midlands Vascular Specialty Trainee, Father and Husband!
ID: 1472579588391899142
19-12-2021 14:48:42
569 Tweet
572 Followers
1,1K Following
Dr. Zeller discusses our reality - our choice of drug/device is dictated more by what’s on our shelf rather than what would be best suited for a specific patient CX Symposium
Dr Schneider highlights in his talk that fluoroscopy does not give us adequate imaging in his talk on vessel preparation Trisha L. Roy MD PhD FACS CX Symposium
Finally!! Great talk on MRI being the workhorse modality in PAD imaging in New Zealand. Imaging protocols need an update in 2025. Alan Lumsden, MD, CV Chairman/Director CX Symposium
Dr Crichton Alexander Crichton presents our AHA study using MRI histo to identify lesions that are high risk for endo failure CX Symposium . Many are hesitant to “bypass first”. We can identify these high risk patients/lesions noninvasively to better inform your patient selection!
Dr Lumsden Alan Lumsden, MD, CV Chairman/Director doing what he does best, presenting the evidence that best guides our treatment for carotid surgery at CXS CX Symposium Trisha L. Roy MD PhD FACS DeBakey CV Education - World Class CV Training Houston Methodist CV Houston Methodist
Another important question from Dr Roy Trisha L. Roy MD PhD FACS regarding the lack histological evidence in vessel preparation devices, often reaching the market without this important evidence CX Symposium Houston Methodist Houston Methodist CV DeBakey CV Education - World Class CV Training Alan Lumsden, MD, CV Chairman/Director
Dr Zeller identifying that plaque morphology needs to guide vessel preparation and must be individualized based on this CX Symposium Trisha L. Roy MD PhD FACS Alan Lumsden, MD, CV Chairman/Director Houston Methodist CV Houston Methodist
Dr Holden talks about QISS MRA, a non contrast technique for imaging patients with CLTI and renal failure - but could it's use could be so much wider CX Symposium Trisha L. Roy MD PhD FACS Alan Lumsden, MD, CV Chairman/Director Houston Methodist CV Houston Methodist
The 3rd revolution in vascular surgery = robotics - Alan Lumsden, MD, CV Chairman/Director presents the path forward and vision for the future of our specialty! CX Symposium
Just back from national surgical research lead meeting The Royal College of Surgeons of England. Amazing to hear about all the incredible research across the UK. The sad truth is that it all could fail if we cannot drive home the message that delivery of clinical research is the responsibility of all surgeons.
Yet another PAD device pulled due to patient injuries. We need rigorous testing. At HMH PVD device core we characterize and test devices in real lesions with actual disease in CLTI patient legs to show you how the device works under the microscope! Alan Lumsden, MD, CV Chairman/Director DeBakey CV Education - World Class CV Training
Join us at the Houston Methodist exhibit booth #247 during the VAM Conference on June 5-6, 2025, in the heart of New Orleans, Louisiana. See you there! Alan Lumsden, MD, CV Chairman/Director #VAM2025 #DeBakeyCVEducation #HoustonMethodist
Had the privilege of presenting the translational talk at Vascular SVS . Thx Kathryn Howe + Translational Science Committee for invite, Sharon C. Kiang, M.D., FACS, FSVS, RPVI for discussion, + mentors Alan Lumsden, MD, CV Chairman/Director, Andrew Dueck , Thomas Forbes , and G Wright: their vision + guidance made it possible.
